Experimental Heart Disease Drug Falls Short of Doctors' Expectations

An experimental drug lowered a common heart attack risk factor but did not deliver the lifesaving benefit doctors had expected, NPR reports.

AI-written summary · The Chestnut Post · November 7, 2026 at 7:30 PM EST · How we use AI

Experimental Heart Disease Drug Falls Short of Doctors' Expectations

An experimental medicine intended to fight heart disease did not deliver the lifesaving benefit doctors had anticipated, according to NPR.

The drug lowers a common risk factor for heart attacks, prompting expectations that it would save patients’ lives. Despite that effect, the medicine made no difference.

Originally reported by NPR. Read the full story at NPR

More U.S. stories

U.S.

Democrats Plan Broader Probes of Fatal ICE Shootings in Minneapolis

After sweeping wins this week, Democrats are expected to renew investigations into the deaths of Renee Good and Alex Pretti in Minneapolis.

AI-written summary · Source: NPR · November 7, 2026 at 7:45 PM EST

U.S.

Darline Graham’s Defeat Divides South Carolina Republicans

South Carolina Republicans split over whether Trump or Lindsey Graham’s team bears responsibility for Darline Graham’s defeat.

AI-written summary · Source: The New York Times · November 7, 2026 at 7:45 PM EST

U.S.

U.S. Homelessness Sees Biggest Drop in Over a Decade, Remains Near 700,000

Homelessness fell last year after record highs, but the Trump administration and advocacy groups differ on what drove the decline.

AI-written summary · Source: NPR · November 7, 2026 at 7:30 PM EST